Modulite®: A means of designing the aerosols generated by pressurized metered dose inhalers

Respiratory Medicine

Volumn 96, Issue SUPPL. 4, 2002, Pages

  Ganderton, D ^a   Lewis, D ^a   Davies, R ^a   Meakin, B ^a   Brambilla, G ^b   Church, T ^a  

^a VECTURA GROUP PLC   (United Kingdom)

^b CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BECLOMETASONE DIPROPIONATE; CHLOROFLUOROCARBON; FLUORINATED HYDROCARBON; GLYCEROL; IPRATROPIUM BROMIDE; MACROGOL; PROPELLANT; WATER; NORFLURANE;

AEROSOL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GEOMETRY; HUMAN; INSPIRATORY CAPACITY; METERED DOSE INHALER; NEBULIZATION; PARTICLE SIZE; PLUME; PRIORITY JOURNAL; REVIEW; VAPOR PRESSURE; ARTICLE; CHEMISTRY; EQUIPMENT DESIGN; NEBULIZER; PRESSURE; STANDARD; VOLATILIZATION;

AEROSOL PROPELLANTS; AEROSOLS; CHEMISTRY, PHARMACEUTICAL; EQUIPMENT DESIGN; HYDROCARBONS, FLUORINATED; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PRESSURE; VOLATILIZATION;

EID: 11144283302     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(02)80018-X     Document Type: Article

References (4)

1. Polli GP, Grim WM, Bacher FA, Yunker MH. Influence of formulation on aerosol particle size. J Pharm Sci 1969; 58: 484-486.
2. Brambilla G, Ganderton D, Garzia R, Lewis D, Meakin B, Ventura P, Modulation of aerosol clouds produced by pressurised inhalation aerosols. Int J Pharm 1999; 186: 53-61.
3. Leach C. Effect of formulation parameters on hydrofluoroalkane- beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol 1999; 104: S250-252.
4. CSM/MCA. Current Problems in Pharmacovigilance. 1999; 25: 5.